Cargando…
Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial
We conducted a non-randomised controlled phase II trial to investigate the role of preoperative administration of interleukin-2 (IL-2) in patients with renal cell carcinoma undergoing tumour nephrectomy. A total of 120 consecutive patients were allocated alternately to the two study groups: perioper...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360567/ https://www.ncbi.nlm.nih.gov/pubmed/17031403 http://dx.doi.org/10.1038/sj.bjc.6603391 |